Society of Nuclear Medicine and Molecular Imaging
Membership association for nuclear medicine and molecular imaging.
Based in VA
🤖
AI Overview
With $1.4M in lobbying spend across 25 quarterly filings, Society of Nuclear Medicine and Molecular Imaging is a significant lobbying presence. They deploy 12 individual lobbyists
$1.4M
Total Lobbying Spend
25
Quarterly Filings
1
Lobbying Firms Used
12
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $50K |
| 2019 | $160K |
| 2020 | $130K |
| 2021 | $110K |
| 2022 | $190K |
| 2023 | $330K |
| 2024 | $180K |
| 2025 | $240K |
Lobbying Firms
ARNOLD & PORTER KAYE SCHOLER LLP
What They Lobby For
- Issues related to access, coverage, payment for cancer drugs.
- Issues related to coverage and payment for radiopharmaceuticals
- Medicare reimbursement of radiopharmaceuticals and nuclear medicine.
- Energy issues regarding nuclear medicine, including domestic supply of Molybdenum-99 and the Nuclear Regulatory Commission.
- Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
- Medicare reimbursement of radiopharmaceuticals and nuclear medicine. Medicare reimbursement of cardiac PET scans.
- Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609). Senate Energy & Water Development Committee Appropriations report language on re-evaluation of nuclear medicine event reporting.
- Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609).
- Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609). Senate and House Energy & Water Development Committee Appropriations report language on re-evaluation of nuclear medicine event reporting.
- Senate and House Energy & Water Development Committee Appropriations report language on nuclear medicine event reporting.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.